Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

National Healthcare (NHC) Return on Sales (2016 - 2025)

National Healthcare's Return on Sales history spans 16 years, with the latest figure at 0.09% for Q4 2025.

  • For Q4 2025, Return on Sales rose 1.0% year-over-year to 0.09%; the TTM value through Dec 2025 reached 0.09%, down 1.0%, while the annual FY2025 figure was 0.09%, 1.0% down from the prior year.
  • Return on Sales reached 0.09% in Q4 2025 per NHC's latest filing, down from 0.11% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.4% in Q2 2021 to a low of 0.01% in Q3 2021.
  • Average Return on Sales over 5 years is 0.08%, with a median of 0.07% recorded in 2024.
  • Peak YoY movement for Return on Sales: rose 27bps in 2021, then crashed -39bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 0.06% in 2021, then crashed by -52bps to 0.03% in 2022, then surged by 274bps to 0.1% in 2023, then decreased by -24bps to 0.08% in 2024, then increased by 13bps to 0.09% in 2025.
  • Per Business Quant, the three most recent readings for NHC's Return on Sales are 0.09% (Q4 2025), 0.11% (Q3 2025), and 0.06% (Q2 2025).